Enveric Biosciences, Inc. (ENVB) income statement
ENVBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.42+0.01 (+0.71%)
Close on Nov 18, 2026Market cap $6.36MP/E –Yield –
Enveric Biosciences, Inc. financial ratios
See a number that looks wrong?